↓ Skip to main content

Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis

Overview of attention for article published in Journal of Translational Medicine, January 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#42 of 4,725)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
19 news outlets
blogs
8 blogs
twitter
42 X users
patent
2 patents
facebook
14 Facebook pages
googleplus
4 Google+ users
reddit
1 Redditor
video
1 YouTube creator

Citations

dimensions_citation
455 Dimensions

Readers on

mendeley
410 Mendeley